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1. Introduction 
Pain is an unpleasant sensory and emotional experience associated with actual or potential 
tissue damage or described in terms of such damage. Due to the fear of pain associated with 
dental injections, some people avoid, cancel, or fail to appear for dental appointments. Pain 
and anxiety control are among the most important aspects in local anesthetic administration 
in dental practice. Administration of local anesthetic produces pain and anxiety that may 
cause subsequent unfavorable behavior (1). As reliable management of pain is an important 
factor in reducing fear and anxiety in dental treatment, clinicians must have a thorough 
knowledge of local anesthetic solutions and techniques. When an agent and a technique are 
chosen, it is important for the clinician to understand the onset, depth, and duration of 
anesthesia in relation to the operative procedure to be performed (2). This chapter 
introduces new local anesthetic formulations, techniques, and postinjection complications in 
dentistry. 
2. Pharmacologic properties of local anesthesia 
The main working principle of local anesthetics is to inhibit the ion flow on nerve cell 
membranes to stabilize membrane potential and block stimulus conduction. Local 
anesthetics can be defined as compounds capable of reversibly suspending the ability of the 
nerve tissue to conduct stimuli (3). 
Local anesthetics consist of a lipophilic aromatic part, which is responsible for the affinity of 
the compound to the nerve cells, joined by a connecting chain to a hydrophilic part that is 
responsible for solubility in water and diffusion among tissues. Decomposition of the 
compound is affected by the nature of the connecting chain, leading to changes in properties 
such as duration of action or toxicity. Local anesthetics can be divided into two groups 
according to the nature of the chemical bonding: esters (e.g., procaine) and amides (e.g., 
lidocaine) (3–4). 
The therapeutic value of such compounds is determined by the typical pharmacological 
properties of local anesthetics. The compound with the longest history of clinical use, 
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procaine, is used as the basis for comparisons of novel agents. The minimum concentration 
at which the anesthetic can block stimulus conduction (potency), the therapeutic value of the 
compound in terms of the correlation between efficacy and tolerability (toxicity), ability of 
the anesthetic compound to reach tissues at some distance from the site of administration 
(diffusibility), duration of anesthesia (duration of action), and metabolism of the anesthetic 
compounds are commonly compared as general pharmacological properties of local 
anesthetics (3–6). 
Vasoconstrictors are added to local anesthetic solutions to inhibit absorption and thus 
prolong the duration of action and reduce the toxicity of anesthetics as well as to achieve a 
suitable blood-free area for surgery. Therefore, it is necessary to take into consideration that 
reactive vasodilatation may occur after surgery with usage of local anesthetics with added 
vasoconstrictors (7–8). 
Adrenaline is the most commonly used vasoconstrictor worldwide. Local anesthetic 
solutions generally contain adrenaline at a concentration of 1 part per 100000 or 1 part per 
200000, resulting in a final content of 0.01–0.005 mg in 1 mL of anesthetic solution. Thus, 
anesthetic solutions contain adrenaline at very low concentrations compared to the levels 
required for general physiological effects in healthy individuals (0.3–0.5 mg by 
subcutaneous administration). There is a great deal of controversy regarding 
contraindications for the use of adrenaline-containing anesthetics. The mode of 
administration and quantity added must also be taken into consideration. The American 
Dental Association and American Heart Association recommend an upper limit of 0.2 mg of 
adrenaline to be administered in dental operations. On the other hand, the low potency of 
anesthetic solutions without adrenaline may lead to pain and elevated levels of stress during 
the operation, resulting in enhanced release of catecholamine (8). 
Noradrenaline is another vasoconstrictor used in anesthetic solutions, which has a much 
weaker local vasoconstrictor effect than adrenaline. Noradrenaline is therefore applied at 
higher concentrations in anesthetic solutions. The most important advantage of 
noradrenaline is that it has no direct effect on the cardiovascular system (6–8). 
3. Clinical properties of local anesthetics 
This section discusses the characteristic clinical properties of the most commonly used local 
anesthetics. 
Procaine: Procaine was synthesized by Einhorn in 1905 and is important in the history of the 
development of local anesthetics, as it was the first compound to be used in humans. 
Although it has been superceded in dental practice by more effective modern drugs, the 
clinical properties of such drugs are still compared with those of procaine as a baseline. 
Procaine is weaker than modern products currently in use in clinical practice. It is highly 
soluble in water, and its hydrochloride salt is used as a local anesthetic. It has a low toxicity 
level and a relatively short duration of action (3,7). 
Lidocaine: Lidocaine is currently the most widely used local anesthetic in clinical practice 
throughout the world. First synthesized by Löfgren and Lundquist in 1943, its potency is 
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fourfold greater than that of procaine, and its toxicity is double that of procaine. The 
duration of action of lidocaine is double that of procaine, and it shows good diffusibility (4). 
Articaine: This preparation, introduced to medical practice by Muschavek and Rippel in 
1974, has similar potency, toxicity, and duration of action to lidocaine. Articaine is used 
almost exclusively in dental practice (7). 
Bupivacaine: The toxicity of bupivacaine is ten times that of procaine and has a longer 
duration of action than lidocaine (7). 
Mepivacaine: The potency and toxicity of mepivacaine are similar to those of lidocaine. 
This agent has a mild vasoconstrictor effect, which leads to a prolonged duration of action 
(5,6). 
Prilocaine: Prilocaine is used in dentistry as a 4% solution containing a vasoconstrictor. This 
agent has potency equivalent to that of procaine and a toxicity level slightly lower than that 
of lidocaine and 1.5 times that of procaine (7). 
4. Methodology of local anesthesia 
Local anesthesia can be classified into two groups according to the manner in which the 
clinician wants to reach the nerve elements to be anesthetized. The term terminal anesthesia, 
also called infiltration anesthesia, is used to explain the mode of anesthesia in which the 
nerve elements are reached at their organ endings, such as the tooth and the periodontal 
membrane. Practically, there are a number of variants, i.e., topical anesthesia, submucosal 
infiltration, intramucosal infiltration, and block anesthesia. The term block anesthesia is 
used to explain blocking of peripheral nerve conduction along the nerve’s course. The 
anesthetic solution is administered at a site some distance from where the clinician wishes to 
apply the anesthesia (6,7,8,12). 
4.1 Anesthesia of upper teeth 
In accordance with the maxillary bone structure, anesthesia of the upper teeth is generally 
performed terminally. The maxilla is covered by a thin cortical layer, and the internal 
structure of the bone is sponge-like, which facilitates diffusion of local anesthetic solution. 
The alternative possibility is the nerve-block method, which can be performed in some cases 
after careful consideration of the advantages and associated risks (7). 
4.2 Anesthesia of lower teeth 
In contrast to the maxilla, the anatomic structural properties of the mandible force the 
practitioner to utilize nerve-block anesthesia methods instead of terminal anesthesia. The 
cortical bone layer that surrounds the mandible is thicker than the maxilla, and the nerve 
fibers lie in deeper bone structures, leading to poor performance of terminal anesthesia 
because of the lack of diffusion of the anesthetic solution into deeper parts of the mandible. 
Therefore, it is essential to be familiar with the anatomical structures and supply areas of the 
nerves to be affected when performing local anesthesia in the mandible. There is still 
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disagreement regarding whether terminal or nerve block anesthesia is the most appropriate 
method for the lower incisors (9–11). 
4.3 Complications of local anesthesia 
Although local anesthesia is commonly defined as a safe and noninvasive procedure, 
some complications have been reported that can be classified into two groups: general and 
local (7). 
General complications are related to the nature and composition of the local anesthetic 
solution. The most important general complications are toxic and allergic in nature, both 
of which are capable of causing death in severe cases. Toxic reactions are rarely seen in 
dentistry, as the quantities of anesthetic agents applied in dentistry and oral surgery are 
generally within safe limits. If overdosing occurs, central nervous system effects 
predominate, and spasms, loss of consciousness, and respiratory depression may occur. It 
is important not to confuse the overdose reactions with those caused by vasoconstrictors. 
Allergic reactions are the other most important general complications of local anesthesia. 
Although allergic reactions caused by local anesthetic solutions with amide linkages are 
extremely rare, clinicians should always be aware of the symptoms of allergic reactions, 
especially in patients with a history of polysensitivity to other compounds (11–14). 
The most common local complications of local anesthesia in dentistry and oral surgery 
practice are hematoma, nerve damage, trismus, facial paralysis, and tongue and lip 
injuries. These local complications may be due to the method of anesthesia used, injury to 
adjacent anatomical structures, or administration of local anesthetic to an inappropriate 
site (11–14). 
4.4 Volume of local anesthesia 
Local anesthesia is not always effective in dentistry. The success of inferior alveolar nerve 
block ranges from 53% to 100%. A higher degree of success would be expected with 
infiltration anesthesia. Nevertheless, infiltration injection is not always 100% successful. This 
can be explained by differences in the smoothness, density, porosity, and thickness of the 
bone surrounding the maxillary teeth, as well as by individual variations in response to the 
drug administered. When only the anterior maxilla teeth are considered for the anesthetic, 
the local anesthetic volume ranges from 0.5 to 1.8 mL (2). Brunetto et al. reported that 1.2 mL 
of 2% lidocaine + 1:100000 epinephrine induced faster onset of pulpal anesthesia, a higher 
success rate, and a longer duration of soft tissue/pulpal anesthesia of the maxilla (2). Cowan 
suggested that doses of less than 0.75 mL of 2% lidocaine + 1:80000 epinephrine were 
adequate for two adjacent teeth after maxillary infiltration. Noncontinuous anesthesia has 
been reported by other groups after inferior alveolar nerve block. This may be the result of 
the equilibrium between ionized and nonionized forms of the anesthetic, which results in 
periods of inadequate pulpal anesthesia (15). 
5. Formulation 
Inferior alveolar nerve (IAN) block is the most frequently used method for achieving local 
anesthesia for mandibular procedures. However, IAN block does not always result in 
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successful pulpal anesthesia. Local anesthetics are chemical compounds that cause 
reversible blockade of nerve impulses. They are weak bases with pKa values between 7.5 
and 9.0, and their physicochemical properties largely determine their clinical anesthetic 
characteristics. Galindo et al. used pH-adjusted local anesthetic solutions (pH 7.4) in 
peripheral nerve block and regional anesthesia and reported better quality of anesthesia 
(16). Davies reviewed the relevant literature and concluded that buffering local anesthetics 
with sodium bicarbonate significantly reduced injection pain (17). 
Whitcomb et al. reported that buffering 2% lidocaine + 1:100000 epinephrine with 0.17 
mEq/mL sodium bicarbonate did not significantly increase the success of anesthesia, 
provide faster onset, or result in less pain at injection compared with unbuffered 2% 
lidocaine + 1:100000 epinephrine for inferior alveolar nerve block. They considered raising 
the pH of the anesthetic formulation to 7.9, which is the acid dissociation constant (pKa) of 
lidocaine, thereby producing equal amounts of the cation and the base form. However, a 
pilot study of various formulations demonstrated irritating effects (cellulitis and tissue 
injury). They found that a concentration of 0.17 mEq/mL of sodium bicarbonate raised the 
pH of the lidocaine formulation to 7.5 without causing an irritating effect. They used a total 
volume of 3.6 mL of the lidocaine/sodium bicarbonate formulation to allow more sodium 
bicarbonate to be used by volume than a volume of 1.8 mL would have allowed. Each 
subject received 72 mg of lidocaine by administration of unbuffered lidocaine, while use of 
buffered lidocaine resulted in administration of only 60 mg of lidocaine. Therefore, subjects 
in the buffered group received 17% less lidocaine. Although less lidocaine was administered 
to patients receiving the buffered formulation, the same success rate of anesthesia was 
achieved as with the unbuffered lidocaine formulation (18). 
Maxillary and mandibular infiltration anesthesia is a common method of anesthetizing 
maxillary and mandibular teeth. Katz et al. reported that success of anesthesia and onset of 
pulpal anesthesia were not significantly different among 2% lidocaine + 1:100000 
epinephrine, 4% prilocaine + 1:200000 epinephrine, and 4% prilocaine for the maxillary 
lateral incisor and first molar. For both the lateral incisor and first molar, 4% prilocaine + 
1: 200000 epinephrine and 2% lidocaine + 1: 100000 epinephrine showed equivalent pulpal 
anesthesia. However, neither agent provided 1 hour of pulpal anesthesia. For both the 
lateral incisor and first molar, 4% prilocaine provided a significantly shorter duration of 
pulpal anesthesia compared with 2% lidocaine + 1: 100000 epinephrine and 4% prilocaine + 
1:200000 epinephrine. Katz et al. suggested that the infiltration injection of 1.8 mL of 2% 
lidocaine + 1: 100000 epinephrine may not always be 100% successful because of individual 
variations in response to the drug administered, operator differences, and variations in 
anatomy and tooth position. The success rate of the infiltration of 4% prilocaine + 1: 200000 
epinephrine was 90% in the lateral incisor and 93% in the first molar. The success of the 
infiltration of 4% prilocaine was 83% in the lateral incisor and 80% in the first molar and 
provided a shorter duration of pulpal anesthesia (19). 
The mandible is comprised of dense, thick cortical bone, and the efficacy of infiltration 
anesthesia for mandibular molars in dental procedures has therefore traditionally been 
considered inadequate. Abdulwahab et al. evaluated the efficacy of six local anesthetic 
formulations (2% lidocaine + 1:100000 epinephrine (L100), 4% articaine + 1:200000 
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epinephrine (A200), 4% articaine + 1:100000 epinephrine (A100), 4% prilocaine + 1:200000 
epinephrine (P200), 3% mepivacaine without vasoconstrictor (Mw/o), and 0.5% bupivacaine 
+ 1:200000 epinephrine (B200) used for posterior mandibular buccal infiltration anesthesia. 
They showed that the maximum mean increases from baseline EPT measurements for the 
six formulations were 43.5% for L100, 44.8% for B200, 51.2% for P200, 66.9% for A200, 68.3% 
for Mw/o, and 77.3% for A100 (A100 vs. L100, P = 0.029). They reported that the mean VAS 
pain ratings for injection pain were 32.2 for B200, 27.6 for L100, 26.2 for A100, 24.1 for A200, 
22.9 for Mw/o, and 21.0 for P200 (20). 
Inferior alveolar nerve block (IANB) is the most frequently used injection technique for 
achieving local anesthesia for mandibular restorative and surgical procedures. In 
asymptomatic patients, inferior alveolar nerve block fails 17–19% of the time in the first 
molar. Therefore, it would be advantageous to improve the success rate of the IANB 
technique. Additionally, slow onset of anesthesia occurs 12–19% of the time in the first 
molar with IANB and the use of articaine or lidocaine solutions. If supplemental buccal 
infiltration can reduce the failure rate and increase the speed of onset of pulpal anesthesia 
after IANB, the technique may be clinically useful. Haase et al. compared the anesthetic 
efficacy of articaine vs. lidocaine as supplemental buccal infiltration of the mandibular first 
molar after inferior alveolar nerve block. They found that with use of the 4% articaine + 
1:100000 epinephrine formulation, successful pulpal anesthesia was achieved for the first 
molar in 88% of cases. With the 2% lidocaine + 1:100000 epinephrine formulation, successful 
pulpal anesthesia occurred in 71% of cases (21). Robertson and colleagues compared the 
degree of pulpal anesthesia achieved with mandibular first molar buccal infiltration of 4% 
articaine + 1:100000 epinephrine and 2% lidocaine + 1:100000 epinephrine. Using the 
lidocaine formulation, they achieved a success rate of 57% for the first molar. Using the 
articaine formulation, they achieved successful pulpal anesthesia in 87% of cases. The 
differences in rates achieved with 2% lidocaine and 4% articaine formulations were 
significant (P < 0.05). Therefore, 4% articaine + 1:100000 epinephrine is superior to 2% 
lidocaine + 1:100000 epinephrine in mandibular buccal infiltration of the first molar. 
However, Robertson and colleagues found that pulpal anesthesia with both the 4% articaine 
and 2% lidocaine formulations declined slowly over 60 minutes (22). Foster et al. 
investigated the anesthetic efficacy of buccal and lingual infiltrations of lidocaine following 
inferior alveolar nerve block in mandibular posterior teeth. They found that adding buccal 
or lingual infiltration of 1.8 mL of 2% lidocaine + 1:100000 epinephrine to IANB did not 
significantly increase the success of anesthesia in mandibular posterior teeth (23). 
Pabst et al. investigated the efficacy of repeated buccal infiltration of articaine in prolonging 
the duration of pulpal anesthesia in the mandibular first molar. The degree of pulpal 
anesthesia obtained with two sets of mandibular first molar buccal infiltrations given in two 
separate doses was examined in 86 adult subjects: an initial infiltration of a cartridge of 4% 
articaine + 1:100000 epinephrine plus a second infiltration of the same anesthetic and dose 
25 minutes after the initial infiltration vs. an initial infiltration of a cartridge of 4% articaine + 
1:100000 epinephrine plus mock repeat infiltration given 25 minutes following the initial 
infiltration. The authors used an electric pulp tester to test the first molar for anesthesia in 3-
minute cycles for 112 minutes after the injections. The repeated infiltration significantly 
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improved pulpal anesthesia from 28 minutes to 109 minutes in the mandibular first molar. 
Repeated infiltration of a cartridge of 4% articaine + 1:100000 epinephrine given 25 minutes 
after the initial infiltration of the same type and dose of anesthetic significantly improved 
the duration of pulpal anesthesia in the mandibular first molar compared with initial buccal 
infiltration alone (24). 
Increasing attention has been focused on the clinical application of -2 adrenoceptor 
agonists for anesthetic management. Furthermore, various methods of administration, 
such as epidural, intrathecal, and peripheral injections, have been examined alone or in 
combination with another drug to prolong and intensify the anesthesia. The -2 
adrenoceptor agonist, clonidine, combined with a local anesthetic, has been found to 
extend the duration of peripheral nerve block. The action of clonidine was suggested to be 
due to local vasoconstriction and/or direct inhibition of impulse conduction in peripheral 
nerves. However, the mechanism of action has not been fully elucidated. Clonidine is not 
particularly specific to -2 adrenoceptors and also acts via -1 adrenoceptors at 
comparatively high concentrations. Clonidine has the ability to induce vasoconstriction, 
and it is therefore unclear whether it acts via -2 adrenoceptors. On the other hand, 
another -2 adrenoceptor agonist, dexmedetomidine, acts more specifically against -2 
adrenoceptors and has more than eight times greater affinity for -2 adrenoceptors of 
clonidine(25). It has sedative, analgesic, and sympatholytic effects that blunt many of the 
cardiovascular responses(hypertension, tachycardia) seen during the perioperative period 
(26). Dexmedetomidine has also been reported to enhance central and peripheral 
neural blockaded by local anesthetics; however, the peripheral effects have not been 
fully clarified. Yoshitomi et al. reported that dexmedetomidine and other 
-2 adrenoceptor agonists (oxymetazoline hydrochloride, yohimbine hydrochloride, 
prazosin hydrochloride) enhanced the local anesthetic action of lidocaine in the periphery 
(25). 
Ketamine is a well-known general anesthetic and short-acting intraoperative analgesic. 
Ketamine has multiple effects throughout the central nervous system, including blocking 
polysynaptic reflexes in the spinal cord and inhibiting excitatory neurotransmitter effects in 
selected areas of the brain. It dissociates the thalamus (which relays sensory impulses from 
the reticular activating system to the cerebral cortex) from the limbic cortex (which is 
involved with the awareness of sedation). While some brain neurons are inhibited, others 
are tonically excited. Clinically, this state of dissociative anesthesia causes the patient to 
appear conscious (eg, eye opening, swallowing, muscle contracture) but unable to process or 
respond to sensory input (26).This agent is a nonselective antagonist of supraspinal N-
methyl-D-aspartate (NMDA) receptors, which are activated by the excitatory 
neurotransmitter glutamate. Inhibition of NMDA receptors decreases neuronal signaling 
and is likely responsible for some of the analgesic effects of ketamine. Satilmis 
et al. demonstrated that the combination of a local anesthetic and subanesthetic doses of 
ketamine during surgical extraction of third molars can produce good local anesthesia while 
affording a comfortable procedure for both surgeon and patient, providing good 
postoperative analgesia with reduced swelling and significantly less trismus than local 
anesthesia alone (27). 
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Failure to achieve anesthesia can be a significant problem in dental practice. Studies have 
shown that more than 50% of adults in the USA miss dentistry services because of a fear of 
pain. Controlling patients’ anxiety and distress, good treatment of root canals, effective use 
of local anesthetics, and drug therapy cover the main factors in the management of dental 
pain. Amitriptyline is one of the most common tricyclic antidepressants (TCAs) and binds to 
pain sensory nerve fibers close to the sodium channels; hence, it may interact to some 
degree with receptors of local anesthetics. Although TCAs have been successfully used in 
the treatment of some types of neuropathic pain and they have been shown to have efficacy 
in blocking Na channels in the nervous system, they have not been used systemically for the 
completion of anesthesia in dental pain because of the potential risks of adverse drug 
reactions. However, topical use of a lipid-soluble TCA, e.g., amitriptyline, administered 
directly into the pulp cavity of a painful tooth in addition to routine local anesthetic 
injection may synergistically complete analgesia through coinhibition of Na channels on 
pain sensory fibers. Moghadamnia et al. reported that inter-pulp-space administration of 2% 
amitriptyline gel for completing analgesia in irreversible pulpitis pain was effective and 
useful as a conjunctive therapy to injection of local anesthetics (28). 
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